Lung cancer clues: tiny particles may predict treatment success
NCT ID NCT07262671
First seen Jan 09, 2026 · Last updated Jun 15, 2026 · Updated 22 times
Summary
This observational study looks at 100 people with advanced non-small cell lung cancer and fluid around the lungs. Researchers collect blood and lung fluid samples before and during standard treatment to see if tiny particles called exosomes can predict how well the therapy works. The goal is to find better ways to match patients to effective treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Cancer hospital of Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.